CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-10 | Pomerantz Roger President and CEO | Sale | −5,989 | $9.05 | $54K | 228,304 |
| 2018-07-10 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −5,989 | 798,546 | ||
| 2018-07-09 | Pomerantz Roger President and CEO | Exercise or conversion | +10,981 | $0.71 | $8K | 239,285 |
| 2018-07-09 | Pomerantz Roger President and CEO | Sale | −10,981 | $9.14 | $100K | 228,304 |
| 2018-07-09 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −10,981 | 804,535 | ||
| 2018-07-06 | Pomerantz Roger President and CEO | Exercise or conversion | +15,366 | $0.71 | $11K | 243,670 |
| 2018-07-06 | Pomerantz Roger President and CEO | Sale | −15,366 | $9.14 | $141K | 228,304 |
| 2018-07-06 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −15,366 | 815,516 | ||
| 2018-06-29 | Pomerantz Roger President and CEO | Exercise or conversion | +4,496 | $0.71 | $3K | 232,800 |
| 2018-06-29 | Pomerantz Roger President and CEO | Sale | −4,496 | $9.10 | $41K | 228,304 |
| 2018-06-29 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −4,496 | 830,882 | ||
| 2018-06-28 | Pomerantz Roger President and CEO | Exercise or conversion | +21,560 | $0.71 | $15K | 249,864 |
| 2018-06-28 | Pomerantz Roger President and CEO | Sale | −21,560 | $9.15 | $197K | 228,304 |
| 2018-06-28 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −21,560 | 835,378 | ||
| 2018-06-27 | Pomerantz Roger President and CEO | Exercise or conversion | +16,991 | $0.71 | $12K | 245,295 |
| 2018-06-27 | Pomerantz Roger President and CEO | Sale | −16,991 | $9.03 | $153K | 228,304 |
| 2018-06-27 | Pomerantz Roger President and CEO | Exercise or conversion · STOCK OPTION (RIGHT TO BUY) | −16,991 | 856,938 | ||
| 2018-06-26 | Dere Willard H Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-26 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-26 | Pomerantz Roger President and CEO | Exercise or conversion | +21,224 | $0.71 | $15K | 249,528 |
Page 27 of 34 · 662 trades